spacer gif spacer gif spacer gif spacer gif ARCHIVE ANNOUNCEMENT! spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 4 October 2006
doi: 10.1242/dev.02589


Development 133, 4269-4279 (2006)
Published by The Company of Biologists 2006


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
dev.02589v1
133/21/4269    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simper-Ronan, R.
Right arrow Articles by Hixson, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simper-Ronan, R.
Right arrow Articles by Hixson, D. C.

Cholangiocyte marker-positive and -negative fetal liver cells differ significantly in their ability to regenerate the livers of adult rats exposed to retrorsine

Rhonda Simper-Ronan, Kate Brilliant, Donna Flanagan, Marie Carreiro, Helen Callanan, Edmond Sabo and Douglas C. Hixson*

Department of Medicine, Division of Hematology and Oncology, Rhode Island Hospital and the Graduate Program in Pathobiology, Brown University Medical School, Providence, RI 02903, USA.

* Author for correspondence (e-mail: dhixson{at}lifespan.org)

Accepted 23 August 2006

We have used monoclonal antibodies against cell-surface developmental epitopes in combination with micromagnetic beads to isolate phenotypically defined subpopulations of cholangiocyte marker-positive fetal liver epithelial cells (CMP-FLEC). Differentiation potential was evaluated by injecting cell isolates from dipeptidyl peptidase IV (DPPIV) positive (DPPIV+) Fischer donor rats into the spleen of partially hepatectomized, DPPIV negative (DPPIV-) Fischer host rats exposed to retrorsine. At various time points, liver tissue was harvested and cells in DPPIV+ colonies were phenotyped by immunofluorescence and histochemical protocols. Functional differentiation and liver replacement were determined by comparing donor and host hepatocyte protein expression patterns and DPPIV enzyme activity in extracts from livers of host rats receiving CMP-FLEC. Our results showed that bipotentiality was retained during differentiation and maturation of CMP-FLEC, indicating that the acquisition of ductal morphology and phenotype were not indicative of lineage commitment. CMP-FLEC transplanted into the adult rat liver lost ductal and gained hepatocyte markers, and acquired protein expression patterns in 2D gels with a close similarity (>75% spot match) to host hepatocytes but differing significantly from the transplanted CMP-FLEC cell isolate (<25% spot match). The average size of donor hepatocyte colonies increased with time so that by 1 year, up to 70% of the host rat liver was replaced by CMP-FLEC derived DPPIV+ hepatocytes. Depletion of CMP-FLEC from fetal liver isolates resulted in a marked decrease in adult liver colonization, suggesting that a high percentage of the hepatocyte colonies in animals receiving total fetal liver isolates are derived from CMP-FLEC.

Key words: Cholangiocyte, Monoclonal antibody, Retrorsine, Partial hepatectomy, Differentiation, Bipotent, Progenitor, Fetal liver, Rat, Micromagnetic bead, Hepatoblast, Non-parenchymal cell, Two dimensional SDS-PAGE, Dipeptidyl peptidase IV, Immunofluorescence, Histochemical stain




This article has been cited by other articles:


Home page
DMMHome page
N. Brezillon, D. Kremsdorf, and M. C. Weiss
Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens
Dis. Model. Mech., September 1, 2008; 1(2-3): 113 - 130.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2006